GlassScriptPhysician profile
John J Orlando
NPI 1295751105
$1,542.59
in general payments reported to CMS, 2019-2025
9 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2021: $448 · 2022: $321 · 2023: $328 · 2024: $115 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $304.29 | 2021-2024 | Nuzyra |
| Biopro, INC. | $276.85 | 2019-2021 | |
| Smith+Nephew, INC. | $230.98 | 2021-2023 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Iodosorb Ointment 40g USA, Acticoat 4" X 4" |
| Alexion Pharmaceuticals, INC. | $210.84 | 2019-2025 | |
| Nevro Corp. | $139.22 | 2022 | |
| Horizon Therapeutics Plc | $124.73 | 2023 | Krystexxa |
| Organogenesis INC. | $103.74 | 2021 | |
| Tactile Systems Technology INC | $79.13 | 2023 | Entre Plus, Flexitouch Plus |
| Grt US Holding, INC. | $72.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Orlando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.